Scinai Immunotherapeutics (SCNI) Current Deferred Revenue (2015 - 2025)
Scinai Immunotherapeutics' Current Deferred Revenue was $90,000 in Q4 2025, down 60.0% from $225,000 a year earlier.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Current Deferred Revenue (2015 - 2025) Analysis & Trends
- In earlier years, Current Deferred Revenue was $225,000 in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,153.65 Bn | 1,122.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.06 Bn | 542.59 Bn | 17.26 Bn |
| 3 | AbbVie | 511.45 Bn | 484.57 Bn | 12.70 Bn |
| 4 | Merck | 365.76 Bn | 320.14 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.05 Bn | 261.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn |
| 7 | Amgen | 234.34 Bn | 189.74 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.16 Bn | 167.36 Bn | 6.22 Bn |
| 9 | Pfizer | 171.51 Bn | 118.16 Bn | 10.94 Bn |
| 10 | Scinai Immunotherapeutics | 159,938.27 | -8.11 Mn | -1.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 90,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Jun 30, 2015 | 2.11 Mn |
API Access
Scinai Immunotherapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SCNI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SCNI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SCNI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();